Lim K-I, Liu C-K, Chen C-L, Wang C-H, Huang C-J, Cheng K-W, Wu S-C, Shih T-H, Yang S-C, Lee Y-E, Jawan B, Juang S-E
Department of Anesthesiology, Kaohsiung Chang Gung Memorial and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Liver Transplantation Program and Surgery, Kaohsiung Chang Gung Memorial and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Transplant Proc. 2016 May;48(4):1074-6. doi: 10.1016/j.transproceed.2015.11.021.
In this study, as our center transitions from using patient-controlled analgesia (PCA) morphine with intravenous (IV) ketorolac to PCA morphine with IV parecoxib, the two regimens are compared in terms of quality of pain control.
Post-operative pain management sheets were collected retrospectively among the living donors of liver transplantation during this transitional period. Group parecoxib was given plain PCA morphine. A single dose of IV parecoxib 40 mg was given 30 minutes before the end of surgery. Group ketorolac was given PCA morphine pre-mixed ketorolac with a concentration of 1.87 mg/mL. Daily and total morphine consumption, Visual Analog Score (VAS), and number of rescue attempts made up to 3 post-operative days, together with satisfaction score and incidence of side effects of PCA usage, were analyzed and compared by means of the Mann-Whitney U test; a value of P < .05 was regarded as significant, and data are given as mean ± SD.
Fifty patients were analyzed; group 1 comprised 21 patients and group 2 comprised 29 patients. There was no difference between group 1 and group 2 in terms of daily VAS. PCA morphine requirements were significantly lower at day 2 and day 3 in group 1. However, the total overall morphine usage and satisfactory score was not statistically different (P = .863, P = .052).
A single dose of IV parecoxib 40 mg can provide satisfactory pain control when paired with PCA morphine for donors undergoing living donor liver transplantation. The use of parecoxib in the multimodal analgesia regimen has similar efficacy, with possibly less morphine consumption, when compared with ketorolac.
在本研究中,随着我们中心从使用静脉注射(IV)酮咯酸的患者自控镇痛(PCA)吗啡过渡到使用IV帕瑞昔布的PCA吗啡,对这两种方案的疼痛控制质量进行了比较。
回顾性收集此过渡期间活体肝移植供体的术后疼痛管理记录。帕瑞昔布组给予普通PCA吗啡。在手术结束前30分钟静脉注射40mg单剂量帕瑞昔布。酮咯酸组给予浓度为1.87mg/mL的PCA吗啡预混酮咯酸。通过Mann-Whitney U检验分析和比较术后3天内的每日和总吗啡消耗量、视觉模拟评分(VAS)、抢救次数,以及PCA使用的满意度评分和副作用发生率;P值<0.05被视为具有统计学意义,数据以平均值±标准差表示。
分析了50例患者;第1组包括21例患者,第2组包括29例患者。两组在每日VAS方面无差异。第1组在第2天和第3天的PCA吗啡需求量显著较低。然而,总的吗啡使用量和满意度评分在统计学上无差异(P = 0.863,P = 0.052)。
对于接受活体肝移植的供体,单剂量静脉注射40mg帕瑞昔布与PCA吗啡联合使用时可提供满意的疼痛控制。与酮咯酸相比,在多模式镇痛方案中使用帕瑞昔布具有相似的疗效,且可能减少吗啡用量。